-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$159.0033.55% Upside
Novo Nordisk A/S Frequently Asked Questions
-
What analysts cover Novo Nordisk A/S?
Novo Nordisk A/S has been rated by research analysts at Cantor Fitzgerald, BMO Capital, Argus Research, Goldman Sachs in the past 90 days.